0% found this document useful (0 votes)
168 views5 pages

1621 Ivermectin Tablet

The document provides guidelines for using Ivermectin (Tab) to treat and prevent COVID-19 infections. It recommends Ivermectin for prophylaxis of contacts exposed to COVID-19, for prophylaxis of healthcare workers, and for treatment of COVID-19 positive patients with mild or no symptoms. Dosages of 200mcg/kg body weight over a period of days are suggested depending on the situation. Safety of the drug and dosing schedules are also covered.

Uploaded by

rajeevsonali
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
168 views5 pages

1621 Ivermectin Tablet

The document provides guidelines for using Ivermectin (Tab) to treat and prevent COVID-19 infections. It recommends Ivermectin for prophylaxis of contacts exposed to COVID-19, for prophylaxis of healthcare workers, and for treatment of COVID-19 positive patients with mild or no symptoms. Dosages of 200mcg/kg body weight over a period of days are suggested depending on the situation. Safety of the drug and dosing schedules are also covered.

Uploaded by

rajeevsonali
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 5

1-Itszl 1-1621 /1:11-5-2020

4trw,
3111fa• 6-r vtrq-,
&ER Tc-04 t144,
dcmMt:4T ii•<-N-11

tar 4,
QT fM4)c-tri crwit th-th
*Into ilL-
119t1, Itszi 31419-W, ‘i“11 12t7T I

thfl'c'(ll 3TTITTI-5 :06 3171-4Tf, 2020


Thisn—colfds-19it twTrir t tciIci kr4 '13qt4I' cj, Ivermectin (Tab)
athrftr wr srzfti-r IV-GNU 41

TF6144,
04.08.2020 611) 4-16IP46t), 114)11 ic4 telltuf acilq, 30.40 Thaf
3i11iafdi ocbril4 fUtiO 4 cj 95 ct1Uj tocr) t46P1-1111 \31-1-61k
14 61-61161 6q Ivermectin (Tab) 4 44-t-T t 3-11 61- # 3-TRIT-
A-ff 66) 416 Or I td-T
,<-1.014 -1 fW:rr t1
cpm qt- 05.08.2020 cri) 951114.), R14)c\91 l.q
-ft- 1R-ezi
'1lIL1 ?I5•<1 ft-19 3ict?91J1 61-64161 t,c4 \i1-1-61k Ivermection
(Tab) S171)-1i -W# \3114 zkf)4--icict T4-%1 - -0-10- 4 4 14

Prophylaxis in contacts :- gt 'd4-'-Ict alit i1hii (contacts) # 41


TP3911* tic041u1 200m./Kg Body Weight 4 t .11-
61- Zr TWA'
1-#74 02 Eru- \31-N1-61 a1t6-0 &,11'ff # 3frird7 12mg. 3t1414 V4-19.
4 -r#r

For Prophylaxis in health care workers :- Thlft-19 \JLITIk


MT:NU .RTiui # ticP9411 GI-G114 200µg./Kg Body Weight 4
Zr 30 # R-1 u2n. aiicRtiTN 915 4 . 6t) 61k Ivermectin Ath#
4 ii4i- .-rft-q.

For treatment of covid Positive :- \JLIzik ml1.s-19 Asymptomatic o Mild


Symptomatic TZ tfiTzif Ivermectin Z&I 200µg./Kg Body Weight tR 42Trf
03 R-f Oct? wri - r? 61k 44-T -9. * 02 tit1 cch el 4 311t- d-9-
12mg. atlisef 4419 66) Wt tuI14 I TITT 5-164'611660-f 100p.g. 3t17.14 Rrr
4 02 GIN 05 R-1- Oct) •T167). I
Tab. Ivermectin 7144th Elth 91ffT3-* 721T 02 Tti 4)1 3TPg
Thsi t 7-rt t

Tab. Doxycyclin TRIM& t4 ziTt 411 -FT311- -211 12 citlt ch4-1 3-11
cP) 1g1 tr 7rt

cicc"I 5 c°5'4 Earl t f4) ctelli \I" ctvl TERedzil


17TH 4)1441g) jP11z1dcl.r<4
31- ci.)
itepricn : iptlatr

'-14414, tfrA

(aiird IN111q)
3TER TC-04 TA-4 I

ifts41-1621 (1) / 1n-5 / 2020, RitwII t I


uI?ikiItT iRiRici cj tfargszrT :-
afcrR- ffc-0:1 114)c-til Rim forrrr, B-ago ireh-r I
f4/19. Tru0-4 nzjfkvr9-, \ic-th ve-zr I
961PaYlch, 114)rdl tf1 tc110-4 tra4, c.cN situ I
14c1), Tt-q-rtr 141, 3oMo, efortd)
.09to9U Q J GTtR cicp, fra)ctil ;It rRezr, \icth Re-zr I
4 1k4 ITT-SC

(itwi 511T feu)


?aft Trft4
04.08.2020 tISI 6 I PIEl I(b, Mt-MT 74 •k7ERP.21 440-, 3090 McV
3TUMMT11 4))ft-19 ii041u1 ‘347.41,1 tate; 4 3T14c1oMdi
twat Aft 1-1
-fri-wr \941-tr 4 311M Auw wr cni4ica
31TI ft911T5 04.082020 it tcINP-ZI 11-4ff, cithith 116IIMIcti, Thi4A-(11 td itTRZT
ZTO (#‘tt) tOStO #111- met aitzterifi tia,#ur \ittew crd qz414
311t4RAfer9 ziler .81
1-th (61 lem-r 41 ft4 Thai "qq)
31TV •#1, r -ri-iRiftra gm 71%1-Err its
i\•-q 1T9 1ktir-45, 4tja <141/to4'1otto, Nr-4)24 eii.ri4)
3.10 •P41c-0•11 qy NYIct) (7-4M2:1), WRW:f TI9, ef(5-Ik31 I
"TO titO*0 Ei.Hd, fkOTT, 'Tqfq tI4501-1, T4F1Q4 11#9, (10-13)
ZCTO 37171, 301:6397 ffi1TFT1t2fl9, i4-115a #131114, *00107#010, citg-Id)
5.ZTO to iD814M, Sit() 1)1tfkIri, *OA° \MDT I
310 141-F, •tac. tacil-ef ate6117, 371M.21 #49., c10-1‘37 I
311
ZTO 8f41Z- Af3R1NO €4eiv4v ffbrdleiL ei(5.1k.t
TO 7#0410 ftt, iPiIN1904101,(1td ki5 &to) itita eitri \.+) I
330 '<Nig fTh.))lui 8TrWet, NiRuf ettrI1/431 I
10.310 YcPvI fict\').-11, .itSWT Thalct>, ttrt trr, tqwzr ei0.1th I
ATTAT #PIctL #-4Fft .v4t vedwrItRtf t-Nircf
lit *44 cb trintd-zr mitd ctr?4 aivrra cfrdur iii t5 Fc9l1-
zit (1109R-r t erg iltrz Ter t -4 twit 0020# .39-c4K frorr-Th--avr
zredti 31--171 T5171 fstr rt){6r t *tic cl11.0# tisiviur t Gitilu 74
Lizik zui-tt41=4-dt t1twthlit 1-114-sr tiA-Pa ti .asr tas alga St 741 t
tai ti fatig ftttrg ZTO IctrChr7 \r4 f410-1-rrute, euc
S01t07rroz10, yi-cpcfroi 4mAmt 4\1u-19 $t 11-zrugtur
til1+.4 T &Tim ctrfla ocntif I5 8t911 213 11 4 a-19 MIN t tiaact
arRrs 74 wr-S <mu' gi FWIN coNui ?area w4I4t €441 tI
1.5
tZT 4 a-19 tiosiui 18 cilt4 t 81141i 919a IT W1711 39 6‘414 41cg
6 t St #1f wr fan /I 01,011 at 4 thwr wrt =Rif *1
p< 3r4-#--1 cmfrir -FS 3tr-4-4-041t-e# tl uls 1970 zi47 7111T41
1/3
4 -ic,
cp1Dicot crqcr)
V 4> TOrt 3#1:ET 9N1 Met 114 I ZrE ate cueiter ter#
Thl" t-t-ef t, .12 T1* 4)Nui 3170[190R0
vti4
artfwirft-e# t-ft cokut *Or ftEt
Sar sfOu *at t t-dwrff
criy31 Rtra t wur ftf49. Ynt4 trfsrati ttt 0-RrNt -Ow trw wpm t
Fkm tst *tr9'i thf *II< -0
fkt Tr±rt fS-4 sr 3t. tiovigm Th-
ufacmfirziut s'r await crNiid digf I elf 31#ftWf Af*)cp-t Rmit'eico i tiw0 at-tar

f$-*0 Tr4 -vOT ti 311tt914-d# vzhir t InqR• 74.1T tispfiul coief


51-1 -Tr TriA-74
t 1 rill ITWR ttir aiEzrzr# arr44-0 whir t
# 4)41
Vtreifi 1414 741 t I *A- CI86 71)11. 64i4eriat 31-1
trf •<)4)2TITI

I LI I LicITI
------------- ----- --- ' 1

t R:rirfb4m- cr4 erET Acr4. tzr ft4


t, tOwni wffirratT afrfl
t fri4 ti ftA
- At Tr& 413tet tiaut ATRoto Trrt i)13ts
349 a .117fr 6'11Z-4eet, -thy Priut
tcfrm, 4)13Rirr,
A-aT4 aRi fairtr-o• Ritdit to to Ittg,
*olro[1401,0, wM1 1/431 ziwi-ff (mica f$ Z1 3ft5a1 ‘31-1-c1N 74 circ414
-rrm
4 -I' 71 gth7r 4 71 •<el t gur nr* WOtfT EFRaffrf T174 arr4 t ed
6I4chtfIcrcilM-f 4 wnir ft Ark tg 11i4 1111T
a-19 ‘<lii Wqr4
13-4 tr f*tcritl gm cog
t, tR-t ty, urdvig *Vi 4 Ft( TR 614 (Ha -st3;c3TE4
444•4 itt71. I 4A 7eu er-4i 4 ft-4 414 *a- trftirr91 iarr-AT 4 rittir
WW14 \T kit-tc4H tg Girfrefft gzi-trr ft-zrr uran
lit 414-d-10 3k
1
3iF1eRR ZTO f4TR)3 31TNIN g atl-a Art441:4-
d9 fri
- 4 kr4 .31-reiK
*54 4 Rti4 Mtge urir ard-Tru CMNI f4) w4r-
,o- 4 ml 441
-Rwr
at
200p.g./Kg Body Weight met t 7wF ef4 3frirdff umg alittft r1-4-R Th
7r41 •qr1tz)1
Wa)ctileig ciRto igen- 3Tri-TekftE9
veFr tioflui tiLtmcnti (1)
Azar 6is#crtilcre4,4tYkr krfWriTrttF
ged-441ir4 col 3r-4-Tru cfrwil Trzrr, \t-pc.rki
kiLtuk wRrffir 4 f$4 Trit zilzt
Tim f4f4 . ñw ' ii 4;400m 4.mq 74 .3qz4H tg Pzi)71. f+-±F ITt
'ISrf fCr —M19.Vf 4 tcli ‘31-ro'd ftttW RID)cticoi §
m4t4 *3117FR t4sh4iul cltivi T4 \ILNI,L 6 P4-I iR fl-
1. Prophylaxis in contacts:- a-19 TE •t1411* .FP: aTR1 cif4rizii (contacts) 4
31141Tita ti509ur aq• 200pg./Kg Body Weight S tf ITZ 04
aram vircr- 4 a0 alf) ftru WO-- 4 Tfia4 Rrf, •<11-.4
02 ‘it<i-cr ititt el 3411c19- 12mg.3fila r419- ittv1i41 4TFR I
For prophylaxis in health care workers:- a-19 -cr4 f*..blul 4 m-rzi-cd
WWI 4474 4 .Litflui 4-414 200pg./Kg Body Weight cfil c! 34 a 79T44
IT17g4 cM.) tigk 7i144 .4 30 4 R-r UP.TT 31IYJc1mg 4ea 916 \cp G41•
lyermectin g417r Thar uil41 WIN!
For treatment of Covid Positive:- 1 /1
4 tiziK t@ Se4U-19 Asymptomatic 4 Mild
Symptomatic lii1Z #11-414 3114 "uIti S 200g./Kg Body Weight tR spa4 03 R-1
Ocb V1.1 i) GIN 4179. 02 liue kv-HIrci aR?5' a4 31)ird" 12mg. W17ir
cm-r so ial 1ITJTtr S. 04 S fite1f4 4 18 mg.)311.1141-r met vit rfsR
gNf aittiffi iTcPTra't Tr-- If 4 gag itatfol
arqTra- cmKu 4Rir f4 *tr efteiRr ere Trne wiTR Oa t uur 10 4_0
(2000pg./Kg Body Weight) deo *--
417r trim-T ck (cNs) WEggiq
-1411.1 4 3il447tire7 S 02 Tt % ibB aiN urt Tirdraii
(Pregnant & lactating Mother) 4 9-6:1 It41- Te0 I

WIC
OUdIII1tU %Nu Li! udi laC
ftttit $ .gt tut $ Ft TT-ea 31-1
-4-11r? ‘54-clpt
2Thiqfti9 •wiR tR $1-41—ger# ft-zir wittI 3Liz1K
i(rAiilfacirr IT ft9 it Tv -Or do WPM fz-ZIT \Ili( a UT 12 clti chq
3111 cl4 trztfrra' rtg1 ftzii vui Tftv
taiii it 7c1RQ-Tu 3TRT fttfit ff21-1 3Tt21T 1T-6)-41 51•<1 "ift lItiffacf
tizLai q altit 'i1t-9-th aro. Im 1 I 0 IITR fdriTer $`1 to$ karrt-o-er1td7
vitt iwted 39uR $"ritz-19 4-4r4 Zirt-S after $fi
itzfr thitrr .wft#
tr-4grq WER "iira tUT tithicr
eirfitzti $ -119 q tigrilq o,..1
7 ,
to q'i itii,
#g-4v1 fAtzr$, tqlt ,(11, .irrpzi 1r-i7, cl(q-lth I
31.0 i'S.Ef In
w--i ai-zi .i)41 1'4477 am-rtt, wr-e_zr 13-qq, wq-ith I •
e,---
.
to \rolto ft*, \W
q td INIIIY C101, ( tt kt3 tato) Ram 6'1 ccf, CVN-Ith I \
310 1 . -417

aii INII-Ri4I11, ( '-r) geiviv ciildzi, doith I


TO 1$R) aplara,
c taciiii aiTiirfR RRTTRUI 117i, eiti-Ith I
\i(g\715
ZTO to -*TIM dirAtAl
V:qo tch'-TR, 4)13Rii, $oAiokrnozio 1
to
*OR 74 fo#Friure, \LAii c -{, $otoviTozio, cru(si th I
to 'tot tfia.,
t7---
fk-air$, -zperzr flit i4r-ivi 1179, ei(qvith 1
310 ‘YLI ctiir tr-- ,
t$ ft 2T), wriv-zr #4#, eitqlth 1
fiirgro
311) '11 -. TI:KR., b--
Mt4r$, it-firt avItototo, iRin:24 17-4, (1G-1i,'

(tov-fro #41)
41511)ait

Otell II ICU VVI LI I totil liSC

You might also like